Fiona Brown
monash.edu
0000-0001-9711-9769
MONASH UNIVERSITY
4 papers found
Refreshing results…
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in Acute Myeloid Leukemia
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
Missing publications? Search for publications with a matching author name.